stoxline Quote Chart Rank Option Currency Glossary
  
Baxter International Inc. (BAX)
33.43  0.24 (0.72%)    05-30 16:00
Open: 33
High: 33.575
Volume: 3,724,280
  
Pre. Close: 33.19
Low: 33
Market Cap: 17,035(M)
Technical analysis
2024-05-30 4:40:00 PM
Short term     
Mid term     
Targets 6-month :  44.28 1-year :  47.84
Resists First :  37.91 Second :  40.95
Pivot price 34.68
Supports First :  33 Second :  27.45
MAs MA(5) :  33.67 MA(20) :  35.12
MA(100) :  39.74 MA(250) :  39.66
MACD MACD :  -1.6 Signal :  -1.6
%K %D K(14,3) :  8.3 D(3) :  8.3
RSI RSI(14): 20.6
52-week High :  50.2 Low :  31.01
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BAX ] has closed above bottom band by 12.3%. Bollinger Bands are 12.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 33.65 - 33.88 33.88 - 34.08
Low: 32.44 - 32.73 32.73 - 32.99
Close: 32.99 - 33.44 33.44 - 33.85
Company Description

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Headline News

Thu, 30 May 2024
Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29 - Simply Wall St

Thu, 30 May 2024
Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29 - Yahoo Finance

Wed, 29 May 2024
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Wed, 29 May 2024
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Wed, 29 May 2024
Reasons to Retain Baxter International (BAX) in Your Portfolio Now - Yahoo Canada Finance

Tue, 28 May 2024
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 510 (M)
Shares Float 507 (M)
Held by Insiders 0.3 (%)
Held by Institutions 92.8 (%)
Shares Short 10,020 (K)
Shares Short P.Month 7,620 (K)
Stock Financials
EPS -0.08
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 16.04
Profit Margin 17.7 %
Operating Margin 10 %
Return on Assets (ttm) 3.5 %
Return on Equity (ttm) -0.5 %
Qtrly Rev. Growth 2.2 %
Gross Profit (p.s.) 0
Sales Per Share 29.22
EBITDA (p.s.) 5.63
Qtrly Earnings Growth -19.8 %
Operating Cash Flow 1,410 (M)
Levered Free Cash Flow 1,580 (M)
Stock Valuations
PE Ratio -417.88
PEG Ratio 3
Price to Book value 2.08
Price to Sales 1.14
Price to Cash Flow 12.08
Stock Dividends
Dividend 0.28
Forward Dividend 0
Dividend Yield 0.8%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android